✨ Free AI Report
Haisco Pharmaceutical Group Co., Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Haisco Pharmaceutical Group Co., Ltd.
Company Research

Haisco Pharmaceutical Group Co., Ltd.: Business Overview, Financials & Competitive Analysis

Haisco Pharmaceutical Group Co., Ltd. scores 6/10 on the AskCyborg Cyborg Score (Solid). Focused regional player with diversified specialty pharmaceutical portfolio positioned for steady growth in expanding Chinese healthcare market. Haisco demonstrates solid fundamentals as an established pharmaceutical player with diverse product portfolio and growing R&D pipeline. However, exposure concentrated in domestic Chinese market and moderate valuation multiples (PE ~198.

What is Haisco Pharmaceutical Group Co., Ltd.'s industry? Haisco Pharmaceutical Group Co., Ltd. (haisco.com) operates in Pharmaceutical Manufacturing & Development. AskCyborg classifies Haisco Pharmaceutical Group Co., Ltd. under Pharmaceutical Manufacturing & Development in its company registry.

Haisco Pharmaceutical Group is a diversified Chinese pharmaceutical manufacturer and R&D company specializing in injectable drugs, with a broad portfolio spanning anesthesia, analgesia, endocrinology, oncology, and li...

6/ 10Solid

Cyborg Score thesis

Focused regional player with diversified specialty pharmaceutical portfolio positioned for steady growth in expanding Chinese...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing & Development
1 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Haisco Pharmaceutical Group Co., Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Haisco Pharmaceutical Group Co., Ltd.

AskCyborg analysts argue the bull and bear cases for Haisco Pharmaceutical Group Co., Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Haisco Pharmaceutical Group Co., Ltd. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Haisco Pharmaceutical Group Co., Ltd. Overview

Pro stress-test →

Haisco Pharmaceutical Group is a diversified Chinese pharmaceutical manufacturer and R&D company specializing in injectable drugs, with a broad portfolio spanning anesthesia, analgesia, endocrinology, oncology, and liver disease treatments. Founded in 2000 and publicly listed since 2012, the company focuses on the domestic Chinese market with a strong emphasis on innovation in specialized drug formulations.

Strategic Profile

Pro stress-test →

Haisco differentiates itself through specialized expertise in high-value injectable medications and multiple late-stage drug candidates in development. The company leverages its manufacturing capabilities and R&D pipeline to address underserved therapeutic areas including non-alcoholic fatty liver disease, advanced solid tumors, and chronic respiratory conditions.

Competitive Landscape

Pro stress-test →

Haisco competes within the fragmented Chinese pharmaceutical market against both state-owned enterprises and private companies. Key competitors include Zhejiang Huahai Pharmaceutical and other regional specialty pharmaceutical manufacturers. The company's focus on high-value injectable formulations and specialized therapeutics provides differentiation from commodity drug producers.

Industry Context

Haisco Pharmaceutical Group Co., Ltd. operates in Pharmaceutical Manufacturing & Development.

Key facts

Founded: 2000 · Headquarters: Shannan, China · Employees: 5,337 · Market cap: 60.03B CNY

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Haisco Pharmaceutical Group Co., Ltd..

  • Strong pipeline of late-stage drug candidates across oncology, hepatology, and respiratory indications signals commitment to innovation beyond legacy products
  • Market cap of ~60B RMB reflects solid valuation in Chinese domestic pharmaceutical space with growing recognition of specialty injectable focus
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • January 2026Q1 2026 earnings release projected for April 23
  • January 2026Stock trading in range of 29.13-62.65 52-week range, recent price ~53-54 RMB
  • +1 moreTrack every material event for Haisco Pharmaceutical Group Co., Ltd. as it happens. Explore monitoring →
Get alerted when Haisco Pharmaceutical Group Co., Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Zhejiang Huahai PharmaceuticalChinese pharmaceutical manufacturer competing in injectable and specialty drugs→

Compare Haisco Pharmaceutical Group Co., Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Haisco Pharmaceutical Group Co., Ltd. operates in Pharmaceutical Manufacturing & Development. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing & Development research →
NEW · MCP server

Ask your AI assistant about Haisco Pharmaceutical Group Co., Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Haisco Pharmaceutical Group Co., Ltd. and its top competitor on Cyborg Score”
“What did Haisco Pharmaceutical Group Co., Ltd. do this quarter?”
“Is Haisco Pharmaceutical Group Co., Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Haisco Pharmaceutical Group Co., Ltd. do?+
Haisco Pharmaceutical Group is a diversified Chinese pharmaceutical manufacturer and R&D company specializing in injectable drugs, with a broad portfolio spanning anesthesia, analgesia, endocrinology, oncology, and li...
What is Haisco Pharmaceutical Group Co., Ltd.'s Cyborg Score?+
Haisco Pharmaceutical Group Co., Ltd. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Haisco Pharmaceutical Group Co., Ltd.'s main competitors?+
Named competitors include Zhejiang Huahai Pharmaceutical. The full competitive landscape is in the AskCyborg report.
How can I get the full Haisco Pharmaceutical Group Co., Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Haisco Pharmaceutical Group Co., Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Haisco Pharmaceutical Group Co., Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.